ArticleJournal of hematology & oncology2016

Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapy.

Gregory S Alexander et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.